Tag Archives: FDA

Twisted web of lies in Maryanne Godboldo Case: Big Pharma, multiple agencies, judge, DHS all profit from child abduction

There is a good chance you have heard the story of Maryanne Godboldo and how armed government agents broke down her door and attempted to kidnap her 13-year-old daughter Ariana to turn over to CPS because she refused to medicate her with a potentially dangerous and mind-altering anti-psychotic drug Risperdal (http://www.naturalnews.com/032191_C…). Maryanne had been using holistic remedies for her daughter instead, such as dance therapy.

The Detroit mother is now currently going through a criminal and custody trial because of this incident, and a variety of revealing and disturbing information is starting to come out about the involvement of Big Pharma and other parties in the twisted web of lies the case is wrapped in.

The jury presiding over the hearing was convinced to believe that Maryanne’s refusal to give her daughter the controversial drug, supposedly used to “treat” ADHD, represented a form of parental neglect. Thanks to the Voice of Detroit (VOD), it is now coming to light that the New Oakland Child-Adolescent & Family Center – a private facility which reported Maryanne to CPS for taking her daughter off the drug — has paid connections with Big Pharma since at least 2004.

Big Pharma’s Slimy Crusade to Push Anti-Psychotics on Kids

In the past decade, America’s pharmaceutical industry has knowingly marketed dozens of dangerous drugs to millions of children, a group that executives apparently view as a lucrative, untapped market for their products. Most kids have no one to look out for their interests except anxious parents who put their trust in doctors. As it turns out, that trust is often misplaced. Big Pharma spends massive amounts to entertain physicians, send them on luxury vacations and ply them with an endless supply of free products. As a result, hundreds of thousands of American kids—some as young as three years old—have become dependent on amphetamines like Adderall and a pharmacopeia of other drugs that allegedly treat depression, insomnia, aggression and other mental health disorders.

Scandalous Off Label Use Of Antipsychotics: Another Warning For DSM-5

I never would have entered the DSM-5 controversy were it not for two of its proposals that risk furthering the already frightening overuse of antipsychotic medication, particularly in children and teenagers. DSM-5 plans to introduce two new and untested diagnoses that would offer natural targets for poor drug prescribing–psychosis risk syndrome (AKA attenuated psychotic symptoms) and temper dysregulation (AKA disruptive mood dysregulation). There is no evidence whatever that antipsychotics would confer any benefit on the kids so labeled (and too often mislabeled), but great reason to worry that this would not stop their being used needlessly and recklessly.

Claim: J&J Wrongly Marketed Antipsychotic Drug Risperdal to Kids

The FDA told Johnson & Johnson (JNJ) in 1997 that its request to market the antipsychotic drug Risperdal for children was “without any justification.” In the following years, J&J’s army of pharmaceutical sales reps made 100,000 sales calls on child and adolescent psychiatrists, justifying this by “qualifying” the docs if they had as few as one adult patient exhibiting signs of schizophrenia, according to a lawsuit.

It was a distinction only a lawyer can love, and now the Massachusetts attorney general is using it against J&J and its Janssen unit, alleging that J&J’s promotion of Risperdal for children was misleading.

Attorney General Alleges Jansen Illegally Marketed Antipsychotic Drug – to kids and the elderly

Drug manufacturer Ortho-McNeil-Janssen is being sued by Attorney General Martha Coakley for illegally marketing Risperdal, an atypical antipsychotic medication. The complaint, filed this week in Suffolk Superior Court, further alleges that Janssen failed to disclose serious risks associated with Risperdal’s use, including the risk of excessive weight gain, diabetes and, for elderly dementia patients, an increased risk of death.